Generate a tailored SOP for Dr. Steven White. Improve your application with a focused, well-structured draft.
Dr. White brings 30 years of experience in the study of asthma, airway inflammation, and airway remodeling, with a long-standing focus on understanding the mechanisms of persistent inflammation and aberrant tissue repair in the lungs. In recent years, his research has increasingly concentrated on the initial cellular response to airway injury, integrating cell biology approaches to uncover early drivers of disease progression. Parallel to this work, Dr. White prioritizes investigating clinical parameters essential for improving care outcomes for patients with asthma. He has successfully led major NIH-funded research projects that required extensive interdisciplinary collaboration, resulting in numerous peer-reviewed publications in leading biomedical journals. As a Principal Investigator for the U19-funded Asthma Allergic Diseases Cooperative Research Center, supported by the National Institute of Allergy and Infectious Diseases (NIAID), Dr. White has helped establish a robust research platform dedicated to understanding severe asthma. His work has evolved into the UG1-funded PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) protocol, a precision medicine initiative aimed at advancing treatment strategies for high-risk asthma populations. In addition to his research, Dr. White co-directs a comprehensive, hospital-wide COPD clinical program focused on reducing readmissions and improving care transitions between inpatient and outpatient community-based medicine. This multidisciplinary effort has achieved significant reductions in readmission rates. Dr. White also oversees a clinical support team responsible for direct patient care and leads innovative work on the role of the airway epithelium and host defense responses to the airway microbiome. His team is currently managing the largest single-center study examining the respiratory microbiome, with a particular emphasis on understanding the interaction between the fungal microbiome (the mycobiome) and bacterial microbiome in asthma. Through these endeavors, Dr. White remains dedicated to the belief that advancing basic and translational lung science will drive the development of effective therapies for asthma and related pulmonary diseases.
University of Chicago • Chicago, IL
Professor in the Department of Medicine with a focus on research in airway epithelial cell biology, airway microbiome, and asthma.
Department of Philosophy